Gang Wei

Luzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Chidamide and Anlotinib act synergistically in Jurkat cells by inhibiting the Hippo signaling pathway.

Chidamide and Anlotinib act synergistically in Jurkat cells by inhibiting the Hippo signaling pathway.

Journal: Biochemistry and biophysics reports
Published: July 30, 2025

Respiratory, thoracic, and mediastinal adverse events associated with ticagrelor: A pharmacovigilance study based on FDA adverse event reporting system.

Respiratory, thoracic, and mediastinal adverse events associated with ticagrelor: A pharmacovigilance study based on FDA adverse event reporting system.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 02, 2025

Case report: Uncontrollable coronary artery perforation caused by severe stenosis proximal to loopy vessels.

Case report: Uncontrollable coronary artery perforation caused by severe stenosis proximal to loopy vessels.

Journal: Frontiers in cardiovascular medicine
Published: April 11, 2025

Advances in ERK Signaling Pathway in Traumatic Brain Injury: Mechanisms and Therapeutic Potential.

Advances in ERK Signaling Pathway in Traumatic Brain Injury: Mechanisms and Therapeutic Potential.

Journal: Neurochemical research
Published: March 27, 2025

Gut microbial metabolite trimethylamine N-oxide as a novel predictor for adverse cardiovascular events after PCI: a systematic review and dose-response meta-analysis.

Gut microbial metabolite trimethylamine N-oxide as a novel predictor for adverse cardiovascular events after PCI: a systematic review and dose-response meta-analysis.

Journal: Nutrition journal
Published: February 15, 2025

A systematic analysis of temporal trends, characteristics, and citations of retracted stem cell publications.

A systematic analysis of temporal trends, characteristics, and citations of retracted stem cell publications.

Journal: BMC medicine
Published: September 15, 2024

Atorvastatin inhibits Lipopolysaccharide (LPS)-induced vascular inflammation to protect endothelium by inducing Heme Oxygenase-1 (HO-1) expression.

Atorvastatin inhibits Lipopolysaccharide (LPS)-induced vascular inflammation to protect endothelium by inducing Heme Oxygenase-1 (HO-1) expression.

Journal: PloS one
Published: April 15, 2024

Zhilong Huoxue Tongyu capsule improves myocardial ischemia/reperfusion injury via the PI3K/AKT/Nrf2 axis.

Zhilong Huoxue Tongyu capsule improves myocardial ischemia/reperfusion injury via the PI3K/AKT/Nrf2 axis.

Journal: PloS one
Published: December 15, 2023

Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysis.

Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysis.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: June 13, 2023

Case report: Fatal traumatic coronary artery dissection-an overlooked complication of chest fracture.

Case report: Fatal traumatic coronary artery dissection-an overlooked complication of chest fracture.

Journal: Frontiers in cardiovascular medicine
Published: May 20, 2023

Changes in the phenotype and function of mucosal-associated invariant T cells in neutrophilic asthma.

Changes in the phenotype and function of mucosal-associated invariant T cells in neutrophilic asthma.

Journal: International immunopharmacology
Published: December 08, 2021

Title of article: Mucosal-associated invariant T cells in lung diseases.

Title of article: Mucosal-associated invariant T cells in lung diseases.

Journal: International immunopharmacology
Published: January 04, 2021
Showing 1-12 of 12

Last Updated: 09/26/2026